Job title: Specialist in Pharmacometry for Personalized Medicine.
Job description: Vivia is pioneering personalizing treatments in blood cancers
by evaluating directly in patient samples the pharmacological effect of
real-life treatments in eliminating individual patient tumor cells. We have
collected a wealth of data on ~40 individual drugs and ~100 drug combination
treatments in terms of dose responses in more than 400 patient samples for 4
indications. Candidate will lead the internal effort to analyze this pioneering
wealth of data with NOMEN and population models. This analysis is achieving 90%
prediction rates enabling launching sales in Q3 2013. This is a key position
within the company and we are flexible on the position and salary based on
candidates profiles.
Job requirements: PhD in pharmacokinetics, pharmacometrics, or related
scientific field Pharmacokinetics and Phamacodynamics. Candidate must have 5-10
years hands-on experience and knowledge of analysis and modeling software (i.e.
NONMEM, Phoenix NLME and CTS, Berkeley Madonna) and statistical software (R,
S+, etc.). We will use NOMMEN 7.2 and population modeling approaches.
Work Environment: This position is based in Madrid, Spain. It requires
significant interactions with internal colleagues from other departments and
with external colleagues and consultants. Vivia provides a highly motivational
environment where all scientists understand that our personalized medicine test
implies that the result of their work every day can mean life or death for an
individual cancer patient, a rare employment opportunity that needs to be taken
into account very seriously.
Vivia Biotech:
Launched in September 2007, Vivia Biotech raised €4 M in seed capital with VC
Funds, a record in Spain, and has recently raised a new round of €7 M to launch
sales of its PM test. Vivia Biotech is worldwide pioneer in the “screening” and
profiling of thousands of drugs on a patient blood samples, thanks to the
ExviTech technological platform. This platform, ExviTech, developed originally
at USA by an American team moved to Spain to start up Vivia, a pioneer company
with international recognition that has been able to take scientific advantage
at Spain’s world leadership in terms of altruistic donation of organs and
samples for research. Vivia´s team is formed by 28 highly qualified
professionals, dedicated to improving the life expectancy and quality of
patients with blood cancers.
Joan Ballesteros, Ph.D.
Chairman & CSO
Vivia Biotech
Spain
Tel: +34 649 872032
Web: http://www.vivibiotech.com